Last reviewed · How we verify

NCT04465136

CES in the Elderly With Generalized Anxiety Disorders

Terminated NA Last updated 14 December 2022
What this trial tests

NA trial testing CES, Alpha-Stim stimulator (Electromedical Products International, Inc., Mineral Wells, Texas, USA) in CES in 27 participants. Terminated before completion.

Timeline
19 February 2021
Primary endpoint
28 November 2022
28 November 2022

Quick facts

Lead sponsorKaohsiung Veterans General Hospital.
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment27
Start date19 February 2021
Primary completion28 November 2022
Estimated completion28 November 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Veterans General Hospital.

Who can join

Adults 60 to 85, any sex, with CES or Anxiety Disorders and Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aimed to investigate whether cranial electrotherapy stimulation(CES) could benefit anxiety symptoms, depressive symptoms, quality of sleep and quality of life in elderly patients with anxiety disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Kaohsiung Veterans General Hospital. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04465136.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing